Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum
Moss Genomics Inc. announces a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000...
We are a public company on the Canadian Stock Exchange with an Ethereum treasury. Our flagship healthcare product, Perennial, is now live!
Tired of trying to understand your bloodwork? We're here to help.
Moss is exploring new ways to leverage the power of the Ethereum blockchain.